(Q35831682)

10 August 2017

1 reference

title

Psychiatric medication induced obesity: an aetiologic review (English)

1 reference

10 August 2017

0 references

Virk S

1

1 reference

10 August 2017

Schwartz TL

2

1 reference

10 August 2017

Jindal S

3

1 reference

10 August 2017

Nihalani N

4

1 reference

10 August 2017

Jones N

5

1 reference

10 August 2017

publication date

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

167-170

1 reference

Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Function and regulation of the beta 3-adrenoceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Neuropharmacology of paradoxic weight gain with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

5-HT2C receptor modulation and the treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

5-HT2C receptor activation decreases appetite and body weight in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Effects of peripheral 5-HT2 and 5-HT3 receptor agonists on food intake in food-deprived and 2-deoxy-D-glucose-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

5-Hydroxytryptaminergic receptor agonists: effects on neuropeptide Y potentiation of feeding and respiratory quotient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Antipsychotic drugs and reproductive hormones: relationship to body weight regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Metabolic changes during treatment with valproate in humans: implication for untoward weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2004.00141.X

10.1111/J.1467-789X.2004.00141.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference